nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprenolol—ADRB3—brown adipose tissue—metabolic syndrome X	0.629	0.739	CbGeAlD
Alprenolol—ADRB3—adipose tissue—metabolic syndrome X	0.0849	0.0997	CbGeAlD
Alprenolol—ADRB1—cardiovascular system—metabolic syndrome X	0.0394	0.0463	CbGeAlD
Alprenolol—ADRB1—adipose tissue—metabolic syndrome X	0.0347	0.0408	CbGeAlD
Alprenolol—HTR1A—cardiovascular system—metabolic syndrome X	0.0338	0.0397	CbGeAlD
Alprenolol—CYP2D6—kidney—metabolic syndrome X	0.0179	0.0211	CbGeAlD
Alprenolol—CYP2D6—liver—metabolic syndrome X	0.0113	0.0133	CbGeAlD
Alprenolol—ADRB3—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.000549	0.0037	CbGpPWpGaD
Alprenolol—HTR1A—G alpha (i) signalling events—CCL5—metabolic syndrome X	0.000544	0.00366	CbGpPWpGaD
Alprenolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.000525	0.00353	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—HTR2C—metabolic syndrome X	0.000495	0.00333	CbGpPWpGaD
Alprenolol—ADRB3—GPCR ligand binding—AGT—metabolic syndrome X	0.000485	0.00327	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—HTR2C—metabolic syndrome X	0.000484	0.00326	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—HTR2C—metabolic syndrome X	0.000473	0.00319	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.000471	0.00317	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—GHRL—metabolic syndrome X	0.000469	0.00316	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—GHRL—metabolic syndrome X	0.000459	0.00309	CbGpPWpGaD
Alprenolol—HTR1A—G alpha (i) signalling events—AGT—metabolic syndrome X	0.000455	0.00306	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.000452	0.00304	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—GHRL—metabolic syndrome X	0.000449	0.00302	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—GHRL—metabolic syndrome X	0.000446	0.00301	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—CNR1—metabolic syndrome X	0.000444	0.00299	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.000442	0.00298	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—CNR1—metabolic syndrome X	0.000434	0.00293	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.000432	0.00291	CbGpPWpGaD
Alprenolol—CYP2D6—Biological oxidations—GGT1—metabolic syndrome X	0.000431	0.0029	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—HTR2C—metabolic syndrome X	0.000428	0.00288	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—CNR1—metabolic syndrome X	0.000425	0.00286	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—CNR1—metabolic syndrome X	0.000423	0.00285	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—GHRL—metabolic syndrome X	0.000405	0.00273	CbGpPWpGaD
Alprenolol—ADRB3—GPCR ligand binding—CCL2—metabolic syndrome X	0.000399	0.00269	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—CNR1—metabolic syndrome X	0.000384	0.00259	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.000378	0.00255	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.00037	0.00249	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—HDAC3—metabolic syndrome X	0.000363	0.00244	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.000362	0.00244	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.000359	0.00242	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.000351	0.00236	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—CCL5—metabolic syndrome X	0.000344	0.00232	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.000343	0.00231	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—CCL5—metabolic syndrome X	0.000337	0.00227	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—CCL5—metabolic syndrome X	0.000329	0.00222	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—CCL5—metabolic syndrome X	0.000328	0.00221	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.000326	0.00219	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000324	0.00218	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.000319	0.00215	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—RBP4—metabolic syndrome X	0.000316	0.00213	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—TRIB3—metabolic syndrome X	0.000316	0.00213	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.000312	0.0021	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.000311	0.0021	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.000305	0.00205	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.000298	0.00201	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—CCL5—metabolic syndrome X	0.000298	0.002	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000296	0.002	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—AGT—metabolic syndrome X	0.000288	0.00194	CbGpPWpGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—TNF—metabolic syndrome X	0.000286	0.00193	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—AGT—metabolic syndrome X	0.000282	0.0019	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—APOC3—metabolic syndrome X	0.00028	0.00189	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.00028	0.00188	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—AGT—metabolic syndrome X	0.000275	0.00185	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—AGT—metabolic syndrome X	0.000274	0.00185	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.000273	0.00184	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.000267	0.0018	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—GHRL—metabolic syndrome X	0.000265	0.00178	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—GHRL—metabolic syndrome X	0.000259	0.00175	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—HTR2C—metabolic syndrome X	0.000254	0.00171	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—GHRL—metabolic syndrome X	0.000253	0.00171	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—HTR2C—metabolic syndrome X	0.000253	0.0017	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—CNR1—metabolic syndrome X	0.000251	0.00169	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—AGT—metabolic syndrome X	0.000249	0.00168	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—HTR2C—metabolic syndrome X	0.000248	0.00167	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—CNR1—metabolic syndrome X	0.000245	0.00165	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CYBA—metabolic syndrome X	0.000245	0.00165	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—HTR2C—metabolic syndrome X	0.000243	0.00164	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—GHRL—metabolic syndrome X	0.000241	0.00162	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—CNR1—metabolic syndrome X	0.00024	0.00162	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—GHRL—metabolic syndrome X	0.00024	0.00161	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—CCL2—metabolic syndrome X	0.000237	0.0016	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—GHRL—metabolic syndrome X	0.000235	0.00159	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—CCL2—metabolic syndrome X	0.000232	0.00156	CbGpPWpGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—IL6—metabolic syndrome X	0.000231	0.00155	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—GHRL—metabolic syndrome X	0.00023	0.00155	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CNR1—metabolic syndrome X	0.000228	0.00153	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CNR1—metabolic syndrome X	0.000227	0.00153	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—CCL2—metabolic syndrome X	0.000227	0.00153	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CNR1—metabolic syndrome X	0.000223	0.0015	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CNR1—metabolic syndrome X	0.000218	0.00147	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—HDAC3—metabolic syndrome X	0.000215	0.00145	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—FMO3—metabolic syndrome X	0.000215	0.00145	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—HDAC3—metabolic syndrome X	0.000211	0.00142	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—HDAC3—metabolic syndrome X	0.000206	0.00139	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—CCL2—metabolic syndrome X	0.000205	0.00138	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—CCL5—metabolic syndrome X	0.000195	0.00131	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000192	0.0013	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—EPHX2—metabolic syndrome X	0.000191	0.00129	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—MLXIPL—metabolic syndrome X	0.000191	0.00129	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—CCL5—metabolic syndrome X	0.00019	0.00128	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000188	0.00127	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—RBP4—metabolic syndrome X	0.000188	0.00126	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TRIB3—metabolic syndrome X	0.000188	0.00126	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—CCL5—metabolic syndrome X	0.000186	0.00125	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—IGF2—metabolic syndrome X	0.000185	0.00125	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MTNR1B—metabolic syndrome X	0.000184	0.00124	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TRIB3—metabolic syndrome X	0.000183	0.00124	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—RBP4—metabolic syndrome X	0.000183	0.00124	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—APOB—metabolic syndrome X	0.00018	0.00121	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—G6PC2—metabolic syndrome X	0.00018	0.00121	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—RBP4—metabolic syndrome X	0.000179	0.00121	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TRIB3—metabolic syndrome X	0.000179	0.00121	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CCL5—metabolic syndrome X	0.000177	0.00119	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000176	0.00118	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CCL5—metabolic syndrome X	0.000176	0.00118	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000175	0.00118	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CCL5—metabolic syndrome X	0.000173	0.00116	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000172	0.00116	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—LPL—metabolic syndrome X	0.000172	0.00116	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CCL5—metabolic syndrome X	0.000169	0.00114	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000168	0.00113	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—APOC3—metabolic syndrome X	0.000166	0.00112	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—AGT—metabolic syndrome X	0.000163	0.0011	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—APOC3—metabolic syndrome X	0.000163	0.00109	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—AGT—metabolic syndrome X	0.000159	0.00107	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—APOC3—metabolic syndrome X	0.000159	0.00107	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—AGT—metabolic syndrome X	0.000156	0.00105	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—FABP4—metabolic syndrome X	0.000153	0.00103	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—HTR2C—metabolic syndrome X	0.00015	0.00101	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—AGT—metabolic syndrome X	0.000148	0.000995	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—AGT—metabolic syndrome X	0.000147	0.00099	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—HTR2C—metabolic syndrome X	0.000147	0.000988	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CYBA—metabolic syndrome X	0.000145	0.000978	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—HSD11B1—metabolic syndrome X	0.000145	0.000976	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—AGT—metabolic syndrome X	0.000145	0.000973	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—APOE—metabolic syndrome X	0.000144	0.00097	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—LEP—metabolic syndrome X	0.000144	0.00097	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—HTR2C—metabolic syndrome X	0.000143	0.000966	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—APOA1—metabolic syndrome X	0.000142	0.000959	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—GHRL—metabolic syndrome X	0.000142	0.000957	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CYBA—metabolic syndrome X	0.000142	0.000957	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—AGT—metabolic syndrome X	0.000141	0.000952	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—GHRL—metabolic syndrome X	0.000139	0.000936	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CYBA—metabolic syndrome X	0.000139	0.000935	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—GHRL—metabolic syndrome X	0.000136	0.000916	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CNR1—metabolic syndrome X	0.000135	0.000907	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CNR1—metabolic syndrome X	0.000132	0.000887	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—G6PD—metabolic syndrome X	0.000129	0.00087	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CNR1—metabolic syndrome X	0.000129	0.000867	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—IRS1—metabolic syndrome X	0.000129	0.000866	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—HDAC3—metabolic syndrome X	0.000126	0.000849	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GCKR—metabolic syndrome X	0.000123	0.00083	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—LPA—metabolic syndrome X	0.000123	0.00083	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—INS—metabolic syndrome X	0.000123	0.000829	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CCL2—metabolic syndrome X	0.000122	0.000819	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CCL2—metabolic syndrome X	0.000121	0.000816	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PLA2G6—metabolic syndrome X	0.000119	0.000804	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—IGF1—metabolic syndrome X	0.000119	0.000802	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CCL2—metabolic syndrome X	0.000119	0.000802	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—APOA5—metabolic syndrome X	0.000118	0.000796	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CCL2—metabolic syndrome X	0.000116	0.000784	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000113	0.000761	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IGF2—metabolic syndrome X	0.00011	0.000741	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—TRIB3—metabolic syndrome X	0.00011	0.00074	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—NOS3—metabolic syndrome X	0.000108	0.000727	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IGF2—metabolic syndrome X	0.000108	0.000725	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—APOB—metabolic syndrome X	0.000107	0.00072	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IGF2—metabolic syndrome X	0.000105	0.000709	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—APOB—metabolic syndrome X	0.000105	0.000704	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CCL5—metabolic syndrome X	0.000104	0.000703	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000104	0.0007	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—APOB—metabolic syndrome X	0.000102	0.000688	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CCL5—metabolic syndrome X	0.000102	0.000687	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—LPL—metabolic syndrome X	0.000102	0.000687	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000102	0.000685	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—LPL—metabolic syndrome X	9.98e-05	0.000672	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CCL5—metabolic syndrome X	9.98e-05	0.000672	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PLA2G4A—metabolic syndrome X	9.94e-05	0.00067	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—NAMPT—metabolic syndrome X	9.86e-05	0.000664	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—LIPC—metabolic syndrome X	9.79e-05	0.00066	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GCK—metabolic syndrome X	9.79e-05	0.00066	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—LPL—metabolic syndrome X	9.76e-05	0.000657	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—APOC3—metabolic syndrome X	9.73e-05	0.000656	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CETP—metabolic syndrome X	9.45e-05	0.000636	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—AKT1—metabolic syndrome X	9.25e-05	0.000623	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—IL6—metabolic syndrome X	9.1e-05	0.000613	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—SCARB1—metabolic syndrome X	9.05e-05	0.000609	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—SREBF1—metabolic syndrome X	8.79e-05	0.000592	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—AGT—metabolic syndrome X	8.73e-05	0.000588	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—LEP—metabolic syndrome X	8.55e-05	0.000576	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—APOE—metabolic syndrome X	8.55e-05	0.000576	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—HMGCR—metabolic syndrome X	8.55e-05	0.000576	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GOT2—metabolic syndrome X	8.55e-05	0.000576	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—AGT—metabolic syndrome X	8.54e-05	0.000575	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—APOA1—metabolic syndrome X	8.45e-05	0.000569	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—AKT1—metabolic syndrome X	8.4e-05	0.000566	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—LEP—metabolic syndrome X	8.37e-05	0.000563	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—APOE—metabolic syndrome X	8.37e-05	0.000563	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—AGT—metabolic syndrome X	8.35e-05	0.000562	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—APOA1—metabolic syndrome X	8.27e-05	0.000557	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—LEP—metabolic syndrome X	8.18e-05	0.000551	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—APOE—metabolic syndrome X	8.18e-05	0.000551	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—APOA1—metabolic syndrome X	8.09e-05	0.000545	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IRS1—metabolic syndrome X	7.63e-05	0.000514	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ABCA1—metabolic syndrome X	7.62e-05	0.000513	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—SLC2A4—metabolic syndrome X	7.62e-05	0.000513	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IRS1—metabolic syndrome X	7.46e-05	0.000503	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GOT1—metabolic syndrome X	7.38e-05	0.000497	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GGT1—metabolic syndrome X	7.38e-05	0.000497	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—INS—metabolic syndrome X	7.31e-05	0.000492	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IRS1—metabolic syndrome X	7.3e-05	0.000491	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CCL2—metabolic syndrome X	7.19e-05	0.000484	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—INS—metabolic syndrome X	7.15e-05	0.000481	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—TGFB1—metabolic syndrome X	7.14e-05	0.000481	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IGF1—metabolic syndrome X	7.07e-05	0.000476	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CCL2—metabolic syndrome X	7.03e-05	0.000474	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—INS—metabolic syndrome X	6.99e-05	0.000471	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IGF1—metabolic syndrome X	6.91e-05	0.000466	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CCL2—metabolic syndrome X	6.88e-05	0.000463	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IGF1—metabolic syndrome X	6.76e-05	0.000455	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—SERPINE1—metabolic syndrome X	6.71e-05	0.000452	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—SERPINE1—metabolic syndrome X	6.56e-05	0.000442	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—SERPINE1—metabolic syndrome X	6.42e-05	0.000432	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NOS3—metabolic syndrome X	6.41e-05	0.000431	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NOS3—metabolic syndrome X	6.27e-05	0.000422	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—APOB—metabolic syndrome X	6.26e-05	0.000422	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NOS3—metabolic syndrome X	6.13e-05	0.000413	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	6.09e-05	0.00041	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—LPL—metabolic syndrome X	5.98e-05	0.000403	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CD36—metabolic syndrome X	5.68e-05	0.000382	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—AKT1—metabolic syndrome X	5.49e-05	0.00037	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—IL6—metabolic syndrome X	5.4e-05	0.000364	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—IL6—metabolic syndrome X	5.38e-05	0.000362	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—AKT1—metabolic syndrome X	5.37e-05	0.000362	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—IL6—metabolic syndrome X	5.29e-05	0.000356	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PPARA—metabolic syndrome X	5.28e-05	0.000356	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—AKT1—metabolic syndrome X	5.25e-05	0.000354	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—IL6—metabolic syndrome X	5.17e-05	0.000348	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—AGT—metabolic syndrome X	5.11e-05	0.000344	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—APOE—metabolic syndrome X	5.01e-05	0.000337	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—AKT1—metabolic syndrome X	4.99e-05	0.000336	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—AKT1—metabolic syndrome X	4.96e-05	0.000334	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—APOA1—metabolic syndrome X	4.95e-05	0.000334	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—AKT1—metabolic syndrome X	4.88e-05	0.000328	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—AKT1—metabolic syndrome X	4.77e-05	0.000321	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PPARG—metabolic syndrome X	4.36e-05	0.000294	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—INS—metabolic syndrome X	4.28e-05	0.000288	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TGFB1—metabolic syndrome X	4.24e-05	0.000285	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TGFB1—metabolic syndrome X	4.14e-05	0.000279	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TGFB1—metabolic syndrome X	4.05e-05	0.000273	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ALB—metabolic syndrome X	3.92e-05	0.000264	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—NOS3—metabolic syndrome X	3.75e-05	0.000253	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	3.43e-05	0.000231	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IL6—metabolic syndrome X	3.19e-05	0.000215	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IL6—metabolic syndrome X	3.12e-05	0.00021	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IL6—metabolic syndrome X	3.05e-05	0.000206	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—AKT1—metabolic syndrome X	2.95e-05	0.000198	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—AKT1—metabolic syndrome X	2.88e-05	0.000194	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—AKT1—metabolic syndrome X	2.82e-05	0.00019	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—AKT1—metabolic syndrome X	1.73e-05	0.000116	CbGpPWpGaD
